51 results

• Vaginal Mesh Settlements Top $2.6B in Payments by Endo to Resolve All Lawsuits

  August 9, 2017

  Irvin Jackson

  Endo Pharmaceuticals plans to pay nearly $800 million to resolve thousands of remaining vaginal mesh lawsuits.

• Vaginal Mesh Manufacturing Unit Shut Down By Endo, After Settling Lawsuits

  March 2, 2016

  Austin Kirk

  Endo has ended all vaginal mesh production by shutting down its Astora Woman's Health division, in order to prevent more vaginal mesh litigation.

• Vaginal Mesh Implants Reclassified As High Risk, Must Go Through Tougher Approval Process

  January 4, 2016

  Irvin Jackson

  The FDA has announce new rules that reclassify transvaginal mesh products as high-risk medical devices and will require them to go through a more stringent approval process showing safety and effectiveness.

• Joint Status Conference Scheduled in All Transvaginal Mesh MDLs With Settlement Counsel

  April 8, 2015

  Austin Kirk

  Another group status conference has been ordered for all vaginal mesh lawsuits in an effort to reach a settlement that would avoid tens of thousands of trials.

• Transvaginal Mesh Settlements Reached to Resolve Nearly All AMS Cases

  October 1, 2014

  Irvin Jackson

  Virtually all AMS vaginal mesh lawsuits have now been settled, with combined payments expected to exceed $1.6 billion.

• Vaginal Mesh, Bladder Sling Lawsuits in MDLs Approach 60,000

  June 18, 2014

  Austin Kirk

  Nearly 60,000 lawsuits involving vaginal mesh and bladder sling products are currently pending in federal MDLs.

• Endo to Pay $830 Million to Settle AMS Vaginal Mesh Lawsuits

  May 1, 2014

  Irvin Jackson

  AMS's parent company, Endo, will pay $830 million to settle most of the vaginal mesh lawsuits against it, the company announced this week.

• Transvaginal Mesh Health Risks Require Reclassification of Devices: FDA

  April 30, 2014

  Irvin Jackson

  The FDA has proposed reclassifying transvaginal mesh products as high-risk medical devices.

• AMS Pelvic Mesh Manufacturing Plant Problems Draw FDA Warning

  April 18, 2014

  Irvin Jackson

  Endo subsidiary AMS has received an FDA warning letter about processes at its Minnesota manufacturing plant, which makes pelvic mesh products that have been the subject of thousands of product liability claims.

• Bard Avaulta Trial To Begin May 19, As Parties Prepare More Cases in MDL

  March 25, 2014

  Austin Kirk

  A postponed Bard Avaulta vaginal mesh trial has been rescheduled for May as a judge prepares the next wave of cases for trial.